Kim Rodriguez brings nearly 20 years of medical device experience in cardiology, radiology, vascular surgery, neurology and women’s health. Kim currently serves as the President and CEO of Acessa Health Inc., a privately held company, developing minimally invasive, uterine sparing solutions for women who suffer from symptomatic fibroids. Prior to Acessa, she served at Spectranetics, as Senior Vice President of the Vascular Intervention business unit, which more than doubled US revenue under her leadership. Prior to Spectranetics, Kim has held several global vice president and management roles in sales, marketing, therapy development and general business management at companies such as Blockade Medical, Stryker Neurovascular, Concentric Medical, Johnson & Johnson, Guidant Corporation and ev3. She received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.